FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications
IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
Health Canada Approves Certolizumab Pegol & NICE Issues Guidance for Certolizumab Pegol
Mirikizumab Promising for Plaque Psoriasis
FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review
Plaque Psoriasis Treatments: BMS-986165 Promising & Adalimumab Biosimilar Demonstrates Equivalence
Revised Application Expected for IV Meloxicam; Plus EU Approves Tildrakizumab
Certolizumab Pegol Receives FDA Approval for Plaque Psoriasis
FDA to Review Abuse-Deterrent Oxycodone Capsule
- 1
- 2
- 3
- …
- 5
- Next Page »